Dr. Reddy's Laboratories Limited
RDY
Price:
$79.59
Market Cap:
$1.11T
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations. This segment also engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for f...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2001-04-11
Stock Exchange
NYSE
Ticker
RDY
The Enterprise Value as of September 2024 (TTM) for Dr. Reddy's Laboratories Limited (RDY) is 1.14T
According to Dr. Reddy's Laboratories Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 1.14T. This represents a change of 13.37% compared to the average of 1.00T of the last 4 quarters.
Dr. Reddy's Laboratories Limited (RDY) Historical Enterprise Value (quarterly & annually)
How has RDY Enterprise Value performed in the past?
The mean historical Enterprise Value of Dr. Reddy's Laboratories Limited over the last ten years is 630.43B. The current 1.14T Enterprise Value has changed 17.94% with respect to the historical average. Over the past ten years (40 quarters), RDY's Enterprise Value was at its highest in in the June 2024 quarter at 1.07T. The Enterprise Value was at its lowest in in the March 2018 quarter at 397.86B.
Average
630.43B
Median
566.42B
Minimum
397.72B
Maximum
1.04T
Dr. Reddy's Laboratories Limited (RDY) Enterprise Value by Quarter and Year
Discovering the peaks and valleys of Dr. Reddy's Laboratories Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 45.20%
Maximum Annual Enterprise Value = 1.04T
Minimum Annual Increase = -17.30%
Minimum Annual Enterprise Value = 397.72B
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 1.04T | 32.41% |
| 2023 | 784.11B | 8.76% |
| 2022 | 720.95B | -5.15% |
| 2021 | 760.10B | 45.20% |
| 2020 | 523.50B | 4.31% |
| 2019 | 501.89B | 26.19% |
| 2018 | 397.72B | -14.39% |
| 2017 | 464.56B | -7.81% |
| 2016 | 503.92B | -17.30% |
| 2015 | 609.34B | 32.91% |
Dr. Reddy's Laboratories Limited (RDY) Average Enterprise Value
How has RDY Enterprise Value performed in the past?
The current Enterprise Value of Dr. Reddy's Laboratories Limited (RDY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
847.78B
5-year avg
765.38B
10-year avg
630.43B
Dr. Reddy's Laboratories Limited (RDY) Enterprise Value vs. Peers
How is RDY’s Enterprise Value compared to its peers?
Dr. Reddy's Laboratories Limited’s Enterprise Value is greater than Pacira BioSciences, Inc. (1.02B), greater than Phibro Animal Health Corporation (1.31B), greater than Collegium Pharmaceutical, Inc. (1.58B), greater than Silver Spike Investment Corp. (38.50M), greater than ANI Pharmaceuticals, Inc. (1.26B), greater than Alkermes plc (4.39B), greater than Intra-Cellular Therapies, Inc. (7.31B), greater than Eagle Pharmaceuticals, Inc. (110.55M), greater than Prestige Consumer Healthcare Inc. (4.73B), greater than Evotec SE (1.37B), greater than Supernus Pharmaceuticals, Inc. (1.71B), greater than Deciphera Pharmaceuticals, Inc. (2.15B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 1.02B | $617.87M | |
| 1.31B | $856.65M | |
| 1.58B | $1.20B | |
| 38.50M | $71.66M | |
| 1.26B | $1.19B | |
| 4.39B | $4.55B | |
| 7.31B | $7.98B | |
| 110.55M | $55.71M | |
| 4.73B | $3.66B | |
| 1.37B | $1.24B | |
| 1.71B | $1.73B | |
| 2.15B | $2.21B |
Build a custom stock screener for Dr. Reddy's Laboratories Limited (RDY) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Dr. Reddy's Laboratories Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Dr. Reddy's Laboratories Limited (RDY) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Dr. Reddy's Laboratories Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Dr. Reddy's Laboratories Limited's Enterprise Value?
What is the highest Enterprise Value for Dr. Reddy's Laboratories Limited (RDY)?
What is the 3-year average Enterprise Value for Dr. Reddy's Laboratories Limited (RDY)?
What is the 5-year average Enterprise Value for Dr. Reddy's Laboratories Limited (RDY)?
How does the current Enterprise Value for Dr. Reddy's Laboratories Limited (RDY) compare to its historical average?